Literature DB >> 17330071

High-throughput electronic biology: mining information for drug discovery.

William Loging1, Lee Harland, Bryn Williams-Jones.   

Abstract

The vast range of in silico resources that are available in life sciences research hold much promise towards aiding the drug discovery process. To fully realize this opportunity, computational scientists must consider the practical issues of data integration and identify how best to apply these resources scientifically. In this article we describe in silico approaches that are driven towards the identification of testable laboratory hypotheses; we also address common challenges in the field. We focus on flexible, high-throughput techniques, which may be initiated independently of 'wet-lab' experimentation, and which may be applied to multiple disease areas. The utility of these approaches in drug discovery highlights the contribution that in silico techniques can make and emphasizes the need for collaboration between the areas of disease research and computational science.

Mesh:

Substances:

Year:  2007        PMID: 17330071     DOI: 10.1038/nrd2265

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  23 in total

1.  Systems chemical biology.

Authors:  Tudor I Oprea; Alexander Tropsha; Jean-Loup Faulon; Mark D Rintoul
Journal:  Nat Chem Biol       Date:  2007-08       Impact factor: 15.040

Review 2.  Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery.

Authors:  Michael R Barnes; Lee Harland; Steven M Foord; Matthew D Hall; Ian Dix; Scott Thomas; Bryn I Williams-Jones; Cory R Brouwer
Journal:  Nat Rev Drug Discov       Date:  2009-07-17       Impact factor: 84.694

3.  Prediction of human functional genetic networks from heterogeneous data using RVM-based ensemble learning.

Authors:  Chia-Chin Wu; Shahab Asgharzadeh; Timothy J Triche; David Z D'Argenio
Journal:  Bioinformatics       Date:  2010-02-04       Impact factor: 6.937

Review 4.  Harnessing systems biology approaches to engineer functional microvascular networks.

Authors:  Lauren S Sefcik; Jennifer L Wilson; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng Part B Rev       Date:  2010-06       Impact factor: 6.389

Review 5.  The emerging paradigm of network medicine in the study of human disease.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

Review 6.  Computational systems chemical biology.

Authors:  Tudor I Oprea; Elebeoba E May; Andrei Leitão; Alexander Tropsha
Journal:  Methods Mol Biol       Date:  2011

7.  Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug.

Authors:  Hee Sook Lee; Taejeong Bae; Ji-Hyun Lee; Dae Gyu Kim; Young Sun Oh; Yeongjun Jang; Ji-Tea Kim; Jong-Jun Lee; Alessio Innocenti; Claudiu T Supuran; Luonan Chen; Kyoohyoung Rho; Sunghoon Kim
Journal:  BMC Syst Biol       Date:  2012-07-02

Review 8.  Rapid analysis of pharmacology for infectious diseases.

Authors:  Andrew L Hopkins; G Richard Bickerton; Ian M Carruthers; Stephen K Boyer; Harvey Rubin; John P Overington
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

9.  Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data.

Authors:  Alexander Aliper; Sergey Plis; Artem Artemov; Alvaro Ulloa; Polina Mamoshina; Alex Zhavoronkov
Journal:  Mol Pharm       Date:  2016-06-08       Impact factor: 4.939

10.  TARGETgene: a tool for identification of potential therapeutic targets in cancer.

Authors:  Chia-Chin Wu; David D'Argenio; Shahab Asgharzadeh; Timothy Triche
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.